Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Exporting Biotechnology Products: A Look at the Issues

Bio/Technology volume 5, pages 46–51 (1987)Cite this article

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Senate Bill Number 1744.

  2. 21 United States Code, section 382(b)(3)(B)(iii)(I).

  3. 21 United States Code, section 382(b)(1).

  4. 21 Code of Federal Regulations, section 314.3(b).

  5. Attachments to statement by Bruce F. Mackler, General Counsel of the Association of Biotechnology Companies (ABC), before the subcommittee on Health and the Environment (April 28, 1986).

  6. 42 United States Code, section 262(h)(1).

  7. 21 Code of Federal Regulations, section 312.110.

  8. 21 Code of Federal Regulations, section 312.110(b)(2)(i).

  9. 21 United States Code, section 381(d)(2).

  10. 21 United States Code, section 381(d)(1).

  11. Medical Devices, Diagnostics, and Instrumentation, 1&W, p.6 (Sept. 29, 1986).

  12. 50 United States Code, sections 2401, et seq.

  13. 15 Code of Federal Regulations, section 399.1, supplement number 1.

  14. 50 Code of Federal Regulations, section 379.

  15. 50 Code of Federal Regulations, section 379.1(a).

  16. Vol 51, Federal Register, p. 39,772 (Oct. 31, 1986).

  17. Vol 51, Federal Register, p. 22,826 (1986).

  18. Letter from Jeffrey N. Gibbs, Associate General Counsel of ABC, to Betty Ferrell, DOC (Aug. 12, 1986).

  19. Birkner, J. 1986. Biotechnology Transfer—National Security Implications, p. 210 in Biotechnology in Society: Private Initiatives and Public Oversight. J. Perpich (ed), Pergamon Press, New York.

    Google Scholar 

  20. Washington Post, p. A17 (Aug. 17, 1986).

Download references

Author information

Authors and Affiliations

  1. a partner in the law firm of Mackler, Cooper, and Gibbs, 1220 L Street, N.W., Washington, D.C., 20005

    Jeffrey N. Gibbs

Authors
  1. Jeffrey N. Gibbs
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gibbs, J. Exporting Biotechnology Products: A Look at the Issues. Nat Biotechnol 5, 46–51 (1987). https://doi.org/10.1038/nbt0187-46

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0187-46

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing